Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PENTAD-FT: Pleural Irrigation vs Intrapleural Fibrinolytic Therapy in Pleural Infection
NCT05903417Completed
- Sponsor
- Universiti Kebangsaan Malaysia
- Start
- Jul 2023
- Primary completion
- Oct 2025
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of tissue-plasminogen activator and dornase alfa in pleural infection (2 arms), sponsored by Universiti Kebangsaan Malaysia. Primary endpoint: Safety Outcome (Clinical Deterioration, Bleeding, etc.) at Day 7. Started Jul 2023; status: completed.
02
Drugs
tissue-plasminogen activatordornase alfa
03
Conditions
pleural infection
Beyond the preview
Go deeper on NCT05903417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05903417.